TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biobact AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
251 |
| Financial expenses |
1
|
11
|
78 |
| Earnings before taxes |
59
|
-120
|
4,854 |
| EBITDA |
-148
|
-184
|
-1,439 |
| Total assets |
1,145
|
3,587
|
5,651 |
| Current assets |
864
|
2,188
|
5,651 |
| Current liabilities |
853
|
53
|
1,998 |
| Equity capital |
292
|
3,534
|
3,653 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
25.5%
|
98.5%
|
64.6% |
| Turnover per employee |
0
|
0
|
126 |
| Profit as a percentage of turnover | 1933.9% | ||
| Return on assets (ROA) |
5.2%
|
-3.0%
|
87.3% |
| Current ratio |
101.3%
|
4128.3%
|
282.8% |
| Return on equity (ROE) |
20.2%
|
-3.4%
|
132.9% |
| Change turnover |
0
|
-251
|
-1,028 |
| Change turnover % |
-100%
|
-80% | |
| Chg. No. of employees |
0
|
-1
|
-2 |
| Chg. No. of employees % |
0%
|
-50%
|
-50% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.